Page last updated: 2024-08-16

salmeterol xinafoate and Long QT Syndrome

salmeterol xinafoate has been researched along with Long QT Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Williams, C	1

Other Studies

1 other study(ies) available for salmeterol xinafoate and Long QT Syndrome

Article	Year
Cause of death in the SMART Trial. Chest, 2006, Volume: 130, Issue:3 Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Black or African American; Cause of Death; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Multicenter Studies as Topic; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta; Reproducibility of Results; Salmeterol Xinafoate; Survival Rate	2006

Article

Year

Cause of death in the SMART Trial.

Chest, 2006, Volume: 130, Issue:3

Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Black or African American; Cause of Death; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Multicenter Studies as Topic; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta; Reproducibility of Results; Salmeterol Xinafoate; Survival Rate

2006